Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA ® ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The treatment of prostate cancer in Uganda follows similar principles to those used worldwide, including surgery, radiation ...

A Nigerian researcher, Dr Jerry Adeyemo, has identified alternative therapies that could help in the treatment of prostate ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...

The widow of a stalwart WA farmer who took his life amid a battle with prostate cancer is calling on politicians to ‘stand up ...

While still investigational, BAT is increasingly explored in clinical settings for patients with progression despite standard hormonal treatments. Though prostate cancer has traditionally been less ...

But he never seemed able to see the same doctor, and when a prostate specific antigen test came back in 2016 showing his ...